Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.17 - $0.26 $11,525 - $17,626
-67,796 Reduced 26.03%
192,696 $33,000
Q2 2022

Aug 15, 2022

SELL
$0.2 - $0.61 $33,676 - $102,713
-168,382 Reduced 39.26%
260,492 $55,000
Q1 2022

May 16, 2022

BUY
$0.48 - $0.74 $20,265 - $31,242
42,220 Added 10.92%
428,874 $266,000
Q4 2021

Feb 14, 2022

BUY
$0.7 - $1.94 $111,201 - $308,186
158,859 Added 69.74%
386,654 $271,000
Q3 2021

Nov 15, 2021

BUY
$1.82 - $5.71 $276,296 - $866,840
151,811 Added 199.79%
227,795 $418,000
Q2 2021

Aug 16, 2021

BUY
$5.22 - $7.33 $396,636 - $556,962
75,984 New
75,984 $442,000

Others Institutions Holding HEXO

About HEXO Corp.


  • Ticker HEXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 601,395,008
  • Description
  • HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up b...
More about HEXO
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.